First-in-human phase I study of CLL-1 CAR-T cells in adults with relapsed/refractory acute myeloid leukemia

Xin Jin(Nankai University), Mingfeng Zhao(Nankai University), Wenyi Lu(Tianjin First Center Hospital), Xia Xiong(Chinese Academy of Sciences), Fan Li(Nankai University), Meng Zhang(Capital Medical University), Jiaxi Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Hongkai Zhang(Nankai University), Xia Xiao(Hebei Medical University), Rui Sun(Tianjin Medical University Eye Hospital), Danni Xie(Tianjin Medical University), Xiaomei Zhang(Tang Hospital), Hairong Lyu(Tianjin First Center Hospital)
Journal of Hematology & Oncology
July 7, 2022
10.1186/s13045-022-01308-1
Cited by 149

Related Papers

Metabolic regulatory crosstalk between tumor microenvironment and tumor-associated macrophages
|Theranostics|2020|397
A RORγt+ cell instructs gut microbiota-specific Treg cell differentiation
|Nature|2022|253
ROS-mediated iron overload injures the hematopoiesis of bone marrow by damaging hematopoietic stem/progenitor cells in mice
|Scientific Reports|2015|143
Effects of Fermented Milk Containing Lacticaseibacillus paracasei Strain Shirota on Constipation in Patients with Depression: A Randomized, Double-Blind, Placebo-Controlled Trial
|Nutrients|2021|134
STAT3 Signaling Is Activated Preferentially in Tumor-Initiating Cells in Claudin-Low Models of Human Breast Cancer
|Stem Cells|2014|111